James George Chopas, VP/Chief Accounting Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 2,064 shares at $21.77 ($45K) on 2026-01-22, disclosed to the SEC on 2026-01-23.
Seasonal sale ($45k) by VP/Chief Accounting Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| APLS | SELL | 2025-09-17 | $5K | — | Filing → |
| APLS | SELL | 2025-09-03 | $15K | — | Filing → |
| APLS | SELL | 2025-03-18 | $5K | — | Filing → |